Topic
Pharmaceuticals
996 published works
Big Molecule Watch
Dualitas Therapeutics and Roche Enter Research Collaboration to Discover and Develop Bispecific Antibodies
On September 17, 2026, Dualitas Therapeutics, Inc. (“Dualitas”) announced a research collaboration and license agreement with Roche to advance novel bispecific antibodies (“BsAbs”) for immunology and inflammation diseases, using Dualitas’…
Big Molecule Watch
GSK to Acquire Trispecific T Cell-Engager for Multiple Myeloma from Chimagen Biosciences
On September 15, 2026, GSK plc (“GSK”) announced that it agreed to acquire a trispecific T cell-engager (“TCE”) from Chimagen Biosciences (“Chimagen”), a privately held biotechnology company. GSK plans to…
The State AG Report
AG Uthmeier Files Lawsuit Against Insulin Manufacturers and Pharmacy Benefit Managers
The post AG Uthmeier Files Lawsuit Against Insulin Manufacturers and Pharmacy Benefit Managers appeared first on The State AG Report.
The State AG Report
AG Marshall Leads Coalition Alerting National Security Council to China Supply Chain Exploitation of FDA-Approved Drugs
The post AG Marshall Leads Coalition Alerting National Security Council to China Supply Chain Exploitation of FDA-Approved Drugs appeared first on The State AG Report.
Duane Morris Life Sciences Law
FDA Launches IND Pilot Program
By Frederick R. Ball, Coleen W. Hill and Kelechi AnyatonwuThe U.S. Food and Drug Administration (FDA) recently announced the final design of its much-anticipated Expedited Investigational New Drug Pilot Program. To participate…
China Law Insight
《医药代表管理办法》实施在即，医药企业学术推广如何转型升级？
By King & Wood
作者：吴巍 刘艳洁 赵妍 2026年5月7日，国家药品监督管理局会同公安部、国家卫生健康委、市场监管总局、国家医保局、国家中医药局、国家疾控局联合公告《医药代表管理办法》。《办法》将于2026年8月1日起施行，《医药代表备案管理办法（试行）》同时废止。这一重磅政策的落地，标志着我国医药代表行业长达六年的“备案试行期”正式落幕，并步入“全链条、强监管、严刑罚”的深水区。 阅读更多
China Law Insight
China to Strengthen Regulation of Medical Representatives and Pharmaceutical Academic Promotion
By King & Wood
Authored by: Huang Ling, Wang Xinghua (Owen), Xu Jiaxing (Jason), Liu Ning and Fang Wei China has issued the Administrative Measures for Medical Representatives, which will take effect on 1…
Freshfields News
Freshfields advises Grünenthal on its acquisition of cancer treatment Stivarga from Bayer
By Freshfields
Global law firm Freshfields is advising Germany-based pharmaceutical company Grünenthal, a global leader in pain management and research, on its agreement with Bayer AG to acquire the cancer treatment Stivarga®…
The Daily Intake
Dietary Supplement Innovation Act Aims to Address Drug Preclusion Concerns
Representative Diana Harshbarger (R-TN) recently introduced the Dietary Supplement Innovation Act (H.R. 10336), legislation that would amend the Federal Food, Drug, and Cosmetic Act's drug preclusion provisions. The bill is…
JURIST
South Korea moves to approve abortion pills for the first time, with rollout expected by 2027
South Korea’s Ministry of Food and Drug Safety on Wednesday stated that it aims to approve the country’s first abortion pill by the first quarter of 2027, filling a legal…